• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨密度和骨形状作为胰岛素样生长因子-I和/或帕米膦酸盐治疗的去卵巢大鼠骨强度的决定因素。

Bone density and shape as determinants of bone strength in IGF-I and/or pamidronate-treated ovariectomized rats.

作者信息

Ammann P, Rizzoli R, Meyer J M, Bonjour J P

机构信息

Division of Clinical Pathophysiology, WHO Collaborating Center for Osteoporosis and Bone Disease, Geneva, Switzerland.

出版信息

Osteoporos Int. 1996;6(3):219-27. doi: 10.1007/BF01622738.

DOI:10.1007/BF01622738
PMID:8783296
Abstract

Areal bone mineral density (BMD) is a major determinant of bone strength and thereby of fracture risk. Other factors including trabecular microarchitecture and bone dimensions also contribute to bone strength. To investigate the relative importance for bone strength of BMD and bone dimensions, the relations between strength and the latter variables were evaluated under different experimental conditions in ovariectomized rats. Bone strength was assessed in compression and bending with measurement of BMD by dual-energy X-ray absorptiometry. Interventions were designed to increase trabecular BMD in rats with estrogen deficiency-induced bone loss (OVX) by treatment with pamidronate, an inhibitor of bone resorption, or to modify bone dimensions, particularly diameter, by administration of the growth factor IGF-I. In OVX rats, pamidronate treatment increased BMD with a commensurate increase in bone strength at the level of lumbar vertebrae and femoral neck (r = 0.789, p < 0.0001 and r = 0.535, p < 0.001, respectively). IGF-I increased the external diameter of midshaft tibia and femoral neck, which also correlated with bone strength (r = 0.678,p < 0.0001 and r = 0.507,p < 0.0002, respectively). Thus, both bone dimensions and BMD contributed to the determination of bone strength. In conclusion, adult rats with estrogen deficiency-induced bone loss represent a useful experimental model for investigating bone strength and its determinants such as BMD and external bone dimensions.

摘要

单位面积骨密度(BMD)是骨强度的主要决定因素,因此也是骨折风险的主要决定因素。其他因素,包括小梁微结构和骨骼尺寸,也对骨强度有影响。为了研究BMD和骨骼尺寸对骨强度的相对重要性,在去卵巢大鼠的不同实验条件下评估了强度与后两个变量之间的关系。通过双能X线吸收法测量BMD,在压缩和弯曲试验中评估骨强度。设计干预措施,通过使用骨吸收抑制剂帕米膦酸盐治疗,增加雌激素缺乏诱导的骨质流失(OVX)大鼠的小梁BMD,或通过给予生长因子IGF-I改变骨骼尺寸,特别是直径。在OVX大鼠中,帕米膦酸盐治疗增加了BMD,同时腰椎和股骨颈水平的骨强度也相应增加(分别为r = 0.789,p < 0.0001和r = 0.535,p < 0.001)。IGF-I增加了胫骨干中段和股骨颈的外径,这也与骨强度相关(分别为r = 0.678,p < 0.0001和r = 0.507,p < 0.0002)。因此,骨骼尺寸和BMD都有助于确定骨强度。总之,雌激素缺乏诱导的骨质流失成年大鼠是研究骨强度及其决定因素(如BMD和骨外径)的有用实验模型。

相似文献

1
Bone density and shape as determinants of bone strength in IGF-I and/or pamidronate-treated ovariectomized rats.骨密度和骨形状作为胰岛素样生长因子-I和/或帕米膦酸盐治疗的去卵巢大鼠骨强度的决定因素。
Osteoporos Int. 1996;6(3):219-27. doi: 10.1007/BF01622738.
2
The new selective estrogen receptor modulator MDL 103,323 increases bone mineral density and bone strength in adult ovariectomized rats.新型选择性雌激素受体调节剂MDL 103,323可提高成年去卵巢大鼠的骨矿物质密度和骨强度。
Osteoporos Int. 1999;10(5):369-76. doi: 10.1007/s001980050242.
3
Dietary essential amino acid supplements increase bone strength by influencing bone mass and bone microarchitecture in ovariectomized adult rats fed an isocaloric low-protein diet.膳食必需氨基酸补充剂通过影响接受等热量低蛋白饮食喂养的去卵巢成年大鼠的骨量和骨微结构来增加骨强度。
J Bone Miner Res. 2002 Jul;17(7):1264-72. doi: 10.1359/jbmr.2002.17.7.1264.
4
Raloxifene and vitamin K2 combine to improve the femoral neck strength of ovariectomized rats.雷洛昔芬与维生素K2联合使用可提高去卵巢大鼠的股骨颈强度。
Calcif Tissue Int. 2005 Aug;77(2):119-26. doi: 10.1007/s00223-004-0277-8. Epub 2005 Jul 28.
5
IGF-I and pamidronate increase bone mineral density in ovariectomized adult rats.胰岛素样生长因子-I和帕米膦酸盐可增加去卵巢成年大鼠的骨矿物质密度。
Am J Physiol. 1993 Nov;265(5 Pt 1):E770-6. doi: 10.1152/ajpendo.1993.265.5.E770.
6
Recovery of proximal tibia bone mineral density and strength, but not cancellous bone architecture, after long-term bisphosphonate or selective estrogen receptor modulator therapy in aged rats.老年大鼠长期使用双膦酸盐或选择性雌激素受体调节剂治疗后,胫骨近端骨矿物质密度和强度恢复,但松质骨结构未恢复。
Bone. 2002 Jan;30(1):195-200. doi: 10.1016/s8756-3282(01)00661-5.
7
Long-term changes in bone mineral and biomechanical properties of vertebrae and femur in aging, dietary calcium restricted, and/or estrogen-deprived/-replaced rats.衰老、饮食钙受限和/或雌激素缺乏/替代大鼠椎骨和股骨的骨矿物质及生物力学特性的长期变化
J Bone Miner Res. 1997 May;12(5):820-31. doi: 10.1359/jbmr.1997.12.5.820.
8
Pamidronate prevents bone loss and decreased bone strength in adult female and male rats fed an isocaloric low-protein diet.帕米膦酸盐可预防成年雌性和雄性大鼠因摄入等热量低蛋白饮食而导致的骨质流失和骨强度下降。
J Bone Miner Res. 2005 Aug;20(8):1365-71. doi: 10.1359/JBMR.050321. Epub 2005 Mar 21.
9
Droloxifene does not blunt bone anabolic effects of prostaglandin E2, but maintains prostaglandin E2-restored bone in aged, ovariectomized rats.屈洛昔芬不会减弱前列腺素E2的骨合成代谢作用,但能维持老年去卵巢大鼠中前列腺素E2恢复的骨量。
Bone. 1999 Jan;24(1):41-7. doi: 10.1016/s8756-3282(98)00146-x.
10
Effects of treatment with parathyroid hormone 1-84 on quantity and biomechanical properties of thoracic vertebral trabecular bone in ovariectomized rhesus monkeys.甲状旁腺激素1-84治疗对去卵巢恒河猴胸椎小梁骨数量和生物力学特性的影响
Calcif Tissue Int. 2008 Mar;82(3):212-20. doi: 10.1007/s00223-008-9108-7. Epub 2008 Feb 23.

引用本文的文献

1
The Role of Osteogenic Effect and Vascular Function in Bone Health in Hypertensive Rats: A Study of Anti-hypertensive and Hemorheologic Drugs.在高血压大鼠的骨骼健康中,成骨效应和血管功能的作用:抗高血压和血液流变学药物的研究。
Calcif Tissue Int. 2024 Mar;114(3):295-309. doi: 10.1007/s00223-023-01170-4. Epub 2023 Dec 15.
2
Comparison of the efficacy between sequential therapy with teriparatide and denosumab and denosumab monotherapy in suppressing fragility fracture risk.比较特立帕肽序贯治疗与地舒单抗及地舒单抗单药治疗抑制脆性骨折风险的疗效。
Osteoporos Int. 2022 Nov;33(11):2409-2416. doi: 10.1007/s00198-022-06495-8. Epub 2022 Aug 4.
3

本文引用的文献

1
Loss of cancellous bone mass and connectivity in ovariectomized rats can be restored by combined treatment with parathyroid hormone and estradiol.卵巢切除大鼠的松质骨量和骨连接性丧失可通过甲状旁腺激素和雌二醇联合治疗得以恢复。
J Clin Invest. 1993 Jun;91(6):2479-87. doi: 10.1172/JCI116483.
2
Predicting vertebral fracture incidence from prevalent fractures and bone density among non-black, osteoporotic women.根据非黑人骨质疏松女性的既往骨折情况和骨密度预测椎体骨折发生率。
Osteoporos Int. 1993 May;3(3):120-6. doi: 10.1007/BF01623272.
3
The effect of aging and ovariectomy on the vertebral bone mass and biomechanical properties of mature rats.
Mechanical basis of bone strength: influence of bone material, bone structure and muscle action.
骨强度的力学基础:骨材料、骨结构及肌肉作用的影响
J Musculoskelet Neuronal Interact. 2017 Sep 1;17(3):114-139.
4
Combined oral administration of bovine collagen peptides with calcium citrate inhibits bone loss in ovariectomized rats.牛胶原蛋白肽与柠檬酸钙联合口服可抑制去卵巢大鼠的骨质流失。
PLoS One. 2015 Aug 10;10(8):e0135019. doi: 10.1371/journal.pone.0135019. eCollection 2015.
5
Do Non-collagenous Proteins Affect Skeletal Mechanical Properties?非胶原蛋白会影响骨骼的力学性能吗?
Calcif Tissue Int. 2015 Sep;97(3):281-91. doi: 10.1007/s00223-015-0016-3. Epub 2015 Jun 6.
6
Osteoprotective effect of extract from Achyranthes japonica in ovariectomized rats.日本牛膝提取物对去卵巢大鼠的骨保护作用。
J Exerc Rehabil. 2014 Dec 31;10(6):372-7. doi: 10.12965/jer.140169. eCollection 2014 Dec.
7
Osteogenic activity of collagen peptide via ERK/MAPK pathway mediated boosting of collagen synthesis and its therapeutic efficacy in osteoporotic bone by back-scattered electron imaging and microarchitecture analysis.胶原肽通过 ERK/MAPK 通路促进胶原合成的成骨活性及其在反散射电子成像和微结构分析骨质疏松骨中的治疗效果。
Molecules. 2013 Dec 12;18(12):15474-89. doi: 10.3390/molecules181215474.
8
Bone quality: the determinants of bone strength and fragility.骨质量:决定骨强度和脆性的因素。
Sports Med. 2014 Jan;44(1):37-53. doi: 10.1007/s40279-013-0100-7.
9
Microarchitecture in focus.聚焦微观结构。
Osteoporos Int. 2010 Jun;21 Suppl 2:S403-6. doi: 10.1007/s00198-010-1242-1. Epub 2010 May 13.
10
Effects of transgenic Pit-1 overexpression on calcium phosphate and bone metabolism.转染 Pit-1 过表达对钙磷和骨代谢的影响。
J Bone Miner Metab. 2010 Mar;28(2):139-48. doi: 10.1007/s00774-009-0121-3. Epub 2009 Oct 1.
Bone. 1993;14(1):1-6. doi: 10.1016/8756-3282(93)90248-9.
4
A murine skeletal adaptation that significantly increases cortical bone mechanical properties. Implications for human skeletal fragility.一种显著增强皮质骨力学性能的小鼠骨骼适应性变化。对人类骨骼脆弱性的影响。
J Clin Invest. 1993 Oct;92(4):1697-705. doi: 10.1172/JCI116756.
5
Long-term osteopenic changes in cancellous bone structure in ovariectomized rats.
Anat Rec. 1993 Jul;236(3):433-41. doi: 10.1002/ar.1092360303.
6
Effects of the bisphosphonate tiludronate on bone resorption, calcium balance, and bone mineral density.双膦酸盐替鲁膦酸钠对骨吸收、钙平衡和骨矿物质密度的影响。
J Bone Miner Res. 1993 Dec;8(12):1491-8. doi: 10.1002/jbmr.5650081212.
7
The positive effect of parathyroid hormone on femoral neck bone strength in ovariectomized rats is more pronounced than that of estrogen or bisphosphonates.
Endocrinology. 1994 Feb;134(2):650-7. doi: 10.1210/endo.134.2.8299562.
8
Mechanical properties, bone mineral content, and bone composition (collagen, osteocalcin, IGF-I) of the rat femur: influence of ovariectomy and nandrolone decanoate (anabolic steroid) treatment.大鼠股骨的力学性能、骨矿物质含量及骨成分(胶原蛋白、骨钙素、胰岛素样生长因子-I):卵巢切除术及癸酸诺龙(一种合成代谢类固醇)治疗的影响
Calcif Tissue Int. 1993 Oct;53(4):269-77. doi: 10.1007/BF01320913.
9
Basic biomechanical measurements of bone: a tutorial.骨骼的基础生物力学测量:教程
Bone. 1993 Jul-Aug;14(4):595-608. doi: 10.1016/8756-3282(93)90081-k.
10
Long-term fracture prediction by bone mineral assessed at different skeletal sites.通过评估不同骨骼部位的骨矿物质进行长期骨折预测。
J Bone Miner Res. 1993 Oct;8(10):1227-33. doi: 10.1002/jbmr.5650081010.